Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
The Journal of Infectious Diseases
|
January 27, 2018
Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection
Adam Rolt, Derek Le, Zongyi Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 27, 2023
In vitro and in vivo pharmacokinetic characterization, chiral conversion and PBPK scaling towards human PK simulation of S-MRI-1867, a drug candidate for Hermansky-Pudlak syndrome pulmonary fibrosis
Elias C Padilha, Mengbi Yang, Pranav Shah, et al.
ACS Pharmacology & Translational Science
|
May 18, 2023
Quantitative Bioactivity Signatures of Dietary Supplements and Natural Products
Adam Yasgar, Danielle Bougie, Richard T Eastman, et al.
ACS Chemical Neuroscience
|
May 20, 2025
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico Study
Delmis E Hernandez, Dan Luo, Thomas E Prisinzano, et al.
Antiviral Research
|
August 8, 2024
Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis
Patrick T Keiser, Wenhan Zhang, Michael Ricca, et al.
Journal of Medicinal Chemistry
|
May 17, 2018
Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity
Shyh-Ming Yang, Natalia J Martinez, Adam Yasgar, et al.
Redox Biology
|
January 29, 2023
Development of an improved and specific inhibitor of NADPH oxidase 2 to treat traumatic brain injury
Hannah Mason, Ganesha Rai, Arina Kozyr, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2021
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection
Khalida Shamim, Miao Xu, Xin Hu, et al.
Journal of Medicinal Chemistry
|
September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells
Ke Kong, Wei Zhao, Jonathan H Shrimp, et al.
Journal of Medicinal Chemistry
|
November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A
John R Horton, Clayton B Woodcock, Qin Chen, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
The Journal of Infectious Diseases
|
January 27, 2018
Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection
Adam Rolt, Derek Le, Zongyi Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 27, 2023
In vitro and in vivo pharmacokinetic characterization, chiral conversion and PBPK scaling towards human PK simulation of S-MRI-1867, a drug candidate for Hermansky-Pudlak syndrome pulmonary fibrosis
Elias C Padilha, Mengbi Yang, Pranav Shah, et al.
ACS Pharmacology & Translational Science
|
May 18, 2023
Quantitative Bioactivity Signatures of Dietary Supplements and Natural Products
Adam Yasgar, Danielle Bougie, Richard T Eastman, et al.
ACS Chemical Neuroscience
|
May 20, 2025
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico Study
Delmis E Hernandez, Dan Luo, Thomas E Prisinzano, et al.
Antiviral Research
|
August 8, 2024
Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis
Patrick T Keiser, Wenhan Zhang, Michael Ricca, et al.
Journal of Medicinal Chemistry
|
May 17, 2018
Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity
Shyh-Ming Yang, Natalia J Martinez, Adam Yasgar, et al.
Redox Biology
|
January 29, 2023
Development of an improved and specific inhibitor of NADPH oxidase 2 to treat traumatic brain injury
Hannah Mason, Ganesha Rai, Arina Kozyr, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2021
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection
Khalida Shamim, Miao Xu, Xin Hu, et al.
Journal of Medicinal Chemistry
|
September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells
Ke Kong, Wei Zhao, Jonathan H Shrimp, et al.
Journal of Medicinal Chemistry
|
November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A
John R Horton, Clayton B Woodcock, Qin Chen, et al.
Page
of 12